Nephropathy in type-1 diabetes
Sawicki, P.T.; Berger, M.
Deutsche Medizinische Wochenschrift 118(9): 319-321
1993
ISSN/ISBN: 0012-0472 PMID: 8444117 Document Number: 414760
Document emailed within 1 workday
Related Documents
Zidek, W. 2004: Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2 MMW Fortschritte der Medizin 146(42): 51-52Esmatjes, E.; Castell, C.; Goday, A.; Montanya, E.; Pou, J.M.; Salinas, I.; Simó, R.; González, M.T.; Tresserras, R.; Lloveras, G. 1998: Prevalence of nephropathy in type i diabetes Medicina Clinica 110(1): 6-10
Żyłka, A.; Gala-Błądzińska, A.; Rybak, K.; Dumnicka, P.; Drożdż, R.; Kuśnierz-Cabala, B. 2015: Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2 Folia Medica Cracoviensia 55(4): 21-33
Chantrel, F.; Bouiller, M.; Kolb, I.; Hannedouche, T. 2000: Antihypertensive treatment in type II diabetes and diabetic nephropathy Nephrologie 21(2): 47-55
Satirapoj, B.; Supasyndh, O.; Dispan, R.; Punpanich, D.; Tribanyatkul, S.; Choovichian, P. 2013: Apolipoprotein e genetic polymorphisms and the development of nephropathy in type 2 diabetes Journal of the Medical Association of Thailand 96(9): 1119-1126
Galicka-Latała, D.; Fedak, D.; Kuźniewski, M.; Kawalec, E.; Solnica, B. 2004: Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus Przeglad Lekarski 61(3): 155-158
Zerbini, G.; Gabellini, D.; Maestroni, S.; Maestroni, A. 2007: Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathy Journal of Nephrology 20(Suppl): S19-S22
Bayazit, A.K.; Yüksel, B.; Noyan, A.ül.; Onenli, N.; Gönlüşen, G.ül.; Ozer, G.ül.; Anarat, A. 2003: Early onset of diabetic nephropathy in a child with type 1 diabetes mellitus Turkish Journal of Pediatrics 45(1): 55-58
Abbas, S.; Raza, S.T.; S Mir, S.; Siddiqi, Z.; Mahdi, F. 2019: No association of SNP 313A→G in GSTP1 with nephropathy, hypertension and dyslipidemia in type 2 diabetes mellitus British Journal of Biomedical Science 76(3): 153-155
Chiasera, J.M.; Ward-Cook, K.M.; McCune, S.A.; Wardlaw, G.M. 2000: Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus Annals of Clinical and Laboratory Science 30(4): 346-353
Onuchin, S.G.; Elsukova, O.S.; Solov'ev, O.V.; Onuchina, E.L. 2010: Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy Klinicheskaia Meditsina 88(1): 32-37
Krairittichai, U.; Potisat, S.; Jongsareejit, A.; Sattaputh, C. 2011: Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 94(Suppl 2): S1-S5
Pierce, H.L.; Stevermer, J.J. 2001: Does losartan (Cozaar) slow the progression of renal disease in patients with type 2 diabetes and nephropathy? Journal of Family Practice 50(12): 1083
Majdan, M.; Kurowska, M.; Orłowska-Kowalik, G.; Drop, A. 2005: Ultrasonographic evaluation of kidneys in type-2 diabetes patients without overt nephropathy and with chronic renal failure Wiadomosci Lekarskie 58(1-2): 25-28
Pagnin, E.; Maiolino, G.; Calò, L.A. 2016: Heme oxygenase-1 in type 2 diabetes: from cell first-line defense to early marker of diabetic nephropathy Minerva Medica 107(2): 123-124
Masuda, H. 2002: Effects of temocapril on the prevention of early diabetic nephropathy in OLETF rat, an animal model for type 2 diabetes Hokkaido Journal of Medical Science 77(5): 419-428
Fomin, V.V. 2012: Fixed dose combinations of antihypertensive drugs and management of risk of development nephropathy in type 2 diabetes mellitus Kardiologiia 52(10): 81-85
Krairittichai, U.; Chaisuvannarat, V. 2009: Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy Journal of the Medical Association of Thailand 92(5): 611-617
Singh, A.; Kalita, B.Chandra. 2020: A Study of Association of XBAI GLUT1 Gene Polymorphism in Patients of Type 2 Diabetes Mellitus with Diabetic Nephropathy Journal of the Association of Physicians of India 68(1): 50
Kazakova, I.A.; Trusov, V.V.; Cheremiskina, I.B. 2003: Clinical significance of assessment of the metabolism of connective-tissue biopolymers in patients with type 1 diabetes mellitus and with diabetic nephropathy Klinicheskaia Laboratornaia Diagnostika 10: 19-22